triamcinolone acetonide immediate release (TCA-IR) / Pacira - LARVOL DELTA

A Study to Evaluate an Intra-Articular Injection of ZILRETTA Versus Triamcinolone Acetonide, Immediate Release in Subjects With Osteoarthritis of the Hip (clinicaltrials.gov) - P2 | N=32 | Recruiting | Sponsor: Pacira Pharmaceuticals, Inc | Trial completion date: Dec 2025 ➔ Apr 2026 | Trial primary completion date: Dec 2025 ➔ Apr 2026

Trial completion date • Trial primary completion date • Immunology • Osteoarthritis • Pain • Rheumatology